EMBC•globenewswire•
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
Summary
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 5, 2026 by globenewswire